Anaphylactic shock to H1 antihistamine drug bilastine: A case report

J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):256-257. doi: 10.1016/j.jaip.2017.07.042. Epub 2017 Sep 19.

Authors

Yann Coattrenec¹, David Spoerl¹, Peter Jandus², Thomas Harr¹

Affiliations

¹ Division of Immunology and Allergology, Department of Medical Specialties, University Hospital and Medical Faculty, Geneva, Switzerland.
² Division of Immunology and Allergology, Department of Medical Specialties, University Hospital and Medical Faculty, Geneva, Switzerland. Electronic address: peter.jandus@hcuge.ch.

PMID: 28939141
DOI: 10.1016/j.jaip.2017.07.042

No abstract available

Publication types

Case Reports

MeSH terms

Allergens / immunology*
Anaphylaxis / diagnosis*
Angioedema
Benzimidazoles / immunology*
Benzimidazoles / therapeutic use
Drug Hypersensitivity / diagnosis*
Female
Histamine H1 Antagonists / immunology*
Histamine H1 Antagonists / therapeutic use
Humans
Middle Aged
Piperidines / immunology*
Piperidines / therapeutic use
Urticaria / diagnosis*
Urticaria / drug therapy

Substances

Allergens
Benzimidazoles
Histamine H1 Antagonists
Piperidines
bilastine